≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of nasopharynx

DOID Endpoint Browser

C3_NASOPHARYNX

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C11
  • Cause of death: ICD-9 — 147
  • Cause of death: ICD-8 — 147
  • Cancer registry: Topography ICD-O-3 — C11
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

123

4. Check minimum number of events

None

123

5. Include endpoints

None

123

6. Filter based on genotype QC (FinnGen only)

104

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 104 42 62
Unadjusted period prevalence (%) 0.02 0.01 0.03
Median age at first event (years) 63.07 57.45 66.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
115
Matched controls
1150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
78.3
66
*
A03FA01
ATC
metoclopramide; systemic, rectal
26.5
74.3
75
76
UDH02
NOMESCO Finland
Rhinopharyngoscopy
29.2
71.9
59
40
WF002
NOMESCO Finland
Radical radiotherapy
+∞
53.4
47
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
797.3
52.9
48
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
+∞
50.9
45
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
43.5
39
*
8070/3-C11.9
ICD-O-3
Squamous cell carcinoma, NOS, of nasopharynx, NOS
+∞
38.8
35
*
N02AA05
ATC
oxycodone; systemic
11.2
38.0
58
96
H02AB02
ATC
dexamethasone; systemic
116.3
37.6
39
5
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
37.6
34
*
XX3DW
NOMESCO Finland
Time consuming IT work
18.9
37.2
33
24
WZC00
NOMESCO Finland
Treatment plan or consultation
10.1
35.4
74
174
C11.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of nasopharynx
+∞
32.9
30
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
13.4
31.0
34
35
A04AA02
ATC
granisetron; systemic, transdermal
+∞
29.4
27
*
A04AA01
ATC
ondansetron; systemic, rectal
33.5
24.7
32
13
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
99.9
22.6
24
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
22.6
21
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
142.2
22.5
23
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
269.1
22.4
22
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
239.5
20.2
20
*
C11.1
ICD-10 Finland
Malignant neoplasm: Posterior wall of nasopharynx
+∞
19.3
18
*
C11.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of nasopharynx
+∞
19.3
18
*
C11.0
ICD-10 Finland
Malignant neoplasm: Superior wall of nasopharynx
+∞
19.3
18
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
19.3
18
*
H65.2
ICD-10 Finland
Chronic serous otitis media
53.8
19.0
22
5
EBA10
NOMESCO Finland
Operative extraction of tooth
7.3
18.7
33
60
SCA02
NOMESCO Finland
Preventive oral health care
8.1
18.6
29
46
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
38.3
17.8
22
7
R13
ICD-10 Finland
Dysphagia
7.7
17.3
28
46
H66.0
ICD-10 Finland
Acute suppurative otitis media
8.9
17.2
24
33
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
17.1
16
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
17.1
16
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.1
16
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
17.2
17.1
27
20
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
36.2
16.8
21
7
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
16.0
15
*
L03AA13
ATC
pegfilgrastim; parenteral
184.0
15.9
16
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.4
15.4
39
99
EP1AE
NOMESCO Finland
Neck ultrasound examination
16.5
15.0
24
18
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
14.9
14
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
13.8
13
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
13.8
13
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.4
13.4
19
10
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
56.9
13.2
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
12.7
12
*
8010/3-C11.9
ICD-O-3
Carcinoma, NOS, of nasopharynx, NOS
+∞
12.7
12
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
24.6
12.4
17
8
ZX090
NOMESCO Finland
Other technic of radiotherapy
132.7
11.7
12
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
132.7
11.7
12
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
11.7
11
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
11.7
11
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.7
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.7
10.9
63
285
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
66.3
10.8
12
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.6
10
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
10.6
10
*
K11.70
ICD-10 Finland
Hypoptyalism
+∞
10.6
10
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
10.6
10
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
15.1
10.6
17
13
UDM02
NOMESCO Finland
Sinoscopy
29.0
10.1
13
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.9
9.8
25
62
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
9.5
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.5
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.5
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
9.5
9
*
JN4AD
NOMESCO Finland
Body CT examination
5.8
9.5
19
38
A07AA02
ATC
nystatin; oral
8.0
9.4
21
31
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.4
9.2
27
75
H66.9
ICD-10 Finland
Otitis media, unspecified
10.9
9.1
17
18
SAA03
NOMESCO Finland
Extended examination of mouth
3.3
9.0
57
265
DHA10
NOMESCO Finland
Biopsy of cavity of nose
15.7
9.0
14
10
EBA15
NOMESCO Finland
Extraction of multiple teeth
13.1
8.9
15
13
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
5.6
8.7
18
37
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
30.1
8.7
11
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
30.1
8.7
11
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
12.1
8.6
15
14
L03AA02
ATC
filgrastim; parenteral
96.9
8.5
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
8.4
8
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
8.4
8
*
8070/3-C11.1
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of nasopharynx
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
8072/3-C11.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasopharynx, NOS
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
DFF00
NOMESCO Finland
Pure tone audiometry
4.0
8.3
27
81
JN4BD
NOMESCO Finland
Extensive body CT
8.0
8.2
18
26
UDC00
NOMESCO Finland
Ear microscopy
4.6
8.0
21
53
R4190
NOMESCO Finland
Nutritional therapy
13.1
7.8
13
11
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
20.0
7.8
11
6
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.4
7.7
21
55
A01AB09
ATC
miconazole; local oral
4.8
7.6
19
46
8070/3-C11.2
ICD-O-3
Squamous cell carcinoma, NOS, of lateral wall of nasopharynx
+∞
7.4
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.4
7
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
21.7
7.3
10
5
JN6AD
NOMESCO Finland
CT of torso and neck
32.2
7.3
9
*
J01CE02
ATC
phenoxymethylpenicillin; oral
3.3
6.9
89
587
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
7.3
6.9
16
25
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.9
6.9
44
200
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
42.6
6.8
8
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
24.2
6.8
9
*
WZC30
NOMESCO Finland
Teaching
3.6
6.7
25
82
K05.31
ICD-10 Finland
Periodontitis pronounced
3.7
6.6
24
77
WF049
NOMESCO Finland
Radiotherapy of metastasis
73.8
6.5
7
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
73.8
6.5
7
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
10.1
6.5
12
13
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
10.1
6.5
12
13
WX110
NOMESCO Finland
Infiltration anesthesia
3.1
6.4
88
589
XW000
NOMESCO Finland
Bone marrow biopsy
19.3
6.4
9
5
Z51.5
ICD-10 Finland
Palliative care
8.5
6.3
13
17
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
10.9
6.2
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
39
27
21.34
45.62
1.6
1.3
—
—
—
0
0
36
98
4.89
12.90
2.1
1.8
—
—
—
0
0
62
273
3.76
11.23
3.1
1.5
—
—
—
0
0
75
390
3.65
10.20
6.4
3.6
33.50
36.04
g/l
2.41
70
370
85
501
3.67
9.04
19.1
6.3
3.94
4.20
e9/l
0.53
72
435
59
294
3.07
8.07
7.9
5.5
—
—
—
0
0
70
388
3.05
7.85
8.0
6.3
1.22
1.21
mmol/l
0.99
65
359
73
417
3.06
7.70
8.3
5.6
2.90
3.11
%
0.30
68
390
73
417
3.06
7.70
8.5
5.6
8.96
8.89
%
0.07
68
391
73
418
3.04
7.65
8.4
5.6
0.70
0.71
%
0.05
68
390
58
301
2.87
7.16
6.4
2.0
2.36
2.35
mmol/l
0.05
52
267
76
459
2.93
6.98
9.4
6.6
1.22
1.21
mmol/l
0.71
68
411
50
247
2.81
6.68
4.1
3.9
—
—
—
0
0
26
90
3.44
6.40
1.6
1.4
—
—
—
0
0
28
105
3.20
6.05
1.6
1.7
—
—
—
0
0
24
82
3.44
6.00
1.4
1.8
—
—
—
0
0
74
470
2.61
5.69
7.9
5.4
0.56
0.57
e9/l
0.09
61
404
75
480
2.62
5.67
8.3
5.4
0.15
0.21
e9/l
3.66
62
419
74
473
2.58
5.57
8.1
5.4
1.52
1.78
e9/l
1.68
65
420
74
473
2.58
5.57
8.1
5.4
0.04
0.04
e9/l
0.51
61
410
18
54
3.77
5.42
1.4
1.5
—
—
—
0
0
70
456
2.37
4.77
16.0
12.2
1.18
1.24
inr
0.43
59
369
18
67
3.00
3.87
1.8
1.1
—
—
—
0
0
46
269
2.18
3.86
2.6
2.0
—
—
—
0
0
7
8
9.22
3.83
1.1
1.1
31.93
24.63
ng/l
—
7
8
60
402
2.03
3.42
2.9
2.4
—
—
estimate
—
0
0
44
265
2.07
3.34
5.3
3.5
7.39
7.40
ph
0.60
31
186
28
146
2.21
3.04
1.8
1.8
—
—
—
0
0
7
13
5.65
2.91
1.3
1.1
—
—
—
0
0
20
92
2.42
2.87
2.9
1.6
387.45
400.94
nmol/l
0.13
20
84
23
115
2.25
2.75
2.2
1.5
—
—
—
0
0
7
16
4.58
2.51
1.9
2.3
—
—
—
0
0
76
903
0.53
2.46
4.7
4.7
1.35
1.32
mmol/l
0.11
69
839
42
275
1.83
2.38
3.6
2.3
333.46
359.42
umol/l
1.01
37
240
81
935
0.55
2.12
5.8
5.5
1.41
1.44
mmol/l
0.24
74
876
38
252
1.76
2.02
12.9
4.0
—
—
—
0
0
7
21
3.48
2.00
1.3
1.0
—
—
—
0
0
25
390
0.54
1.96
3.0
3.6
—
—
—
0
0
6
16
3.89
1.96
1.3
1.3
—
—
—
0
0
83
938
0.59
1.68
5.6
5.6
4.73
4.55
mmol/l
0.79
76
883
14
71
2.11
1.62
4.3
4.4
0.78
0.24
%
—
9
17
13
64
2.16
1.61
1.4
1.3
—
—
—
0
0
33
224
1.66
1.58
4.1
4.0
385.56
313.79
ng/l
0.07
27
183
86
954
0.61
1.40
6.5
6.4
2.79
2.64
mmol/l
0.69
77
894
24
156
1.68
1.34
3.0
2.8
3.05
1.50
e6/l
0.56
12
71
14
77
1.93
1.32
6.9
4.3
1.00
0.88
%
—
9
20
83
924
0.63
1.29
5.3
5.4
6.06
6.05
mmol/l
0.01
76
854
34
245
1.55
1.26
1.5
1.4
—
—
—
0
0
0
34
0.00
1.18
0.0
3.1
—
3.94
—
0
34
13
73
1.88
1.16
7.3
4.4
0.00
0.13
%
—
8
16
26
187
1.50
0.96
2.3
1.3
2.43
2.94
g/l
0.69
18
107
83
908
0.69
0.93
5.9
7.1
39.24
39.68
mmol/mol
0.21
74
863
6
28
2.20
0.93
4.5
1.6
—
—
—
0
0
6
29
2.13
0.91
1.2
1.6
—
—
—
0
0
29
375
0.70
0.89
3.1
3.3
7.31
8.00
mmol/l
0.44
23
325
49
406
1.36
0.84
13.9
10.1
0.00
0.00
e9/l
0.50
35
333
10
59
1.76
0.78
6.0
3.5
1.22
1.21
mmol/l
—
10
51
6
34
1.81
0.77
2.3
1.6
—
—
—
0
0
29
366
0.72
0.75
2.8
3.4
7.56
51.93
mg/l
4.10
18
248
5
25
2.04
0.73
8.0
4.1
—
—
—
0
0
15
103
1.52
0.69
2.6
3.4
7.41
7.38
ph
—
8
61
26
200
1.39
0.69
6.2
4.0
—
—
—
0
0
12
78
1.60
0.68
7.5
4.7
0.00
0.00
%
—
7
14
29
228
1.36
0.67
2.0
2.1
2.73
2.73
mg/l
0.01
23
198
5
28
1.82
0.67
1.4
1.4
—
—
—
0
0
9
60
1.54
0.56
14.9
11.5
25.66
24.52
mmol/l
—
9
60
18
138
1.36
0.49
1.3
1.2
—
—
—
0
0
39
334
1.25
0.49
5.8
3.5
33.36
83.73
e6/l
0.63
29
233
7
48
1.49
0.48
2.9
2.4
—
—
—
0
0
14
185
0.72
0.48
1.3
1.3
9.62
29.49
iu/ml
—
6
60
35
297
1.26
0.47
4.3
2.8
26.92
248.10
e6/l
0.49
28
221
36
415
0.81
0.45
2.0
2.0
1.49
1.37
mmol/l
0.29
30
352
6
91
0.64
0.44
1.7
1.4
—
—
—
0
0
40
455
0.81
0.44
5.5
4.2
2.32
1.89
ug/l
0.45
34
408
100
957
1.34
0.43
31.7
17.5
4.02
4.01
mmol/l
0.18
100
939
41
359
1.22
0.42
5.5
3.7
—
—
—
0
0
32
371
0.81
0.41
3.5
4.1
0.98
7.75
mg/mmol
3.11
19
245
0
18
0.00
0.40
0.0
2.2
—
11.11
—
0
18
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
5
76
0.64
0.37
28.6
11.2
0.84
1.37
%
—
5
76
6
43
1.42
0.35
1.3
1.3
—
—
—
0
0
23
271
0.81
0.34
4.0
3.2
0.00
0.00
estimate
—
5
73
99
955
1.26
0.32
31.8
17.4
138.39
139.82
mmol/l
3.43
99
938
29
252
1.20
0.31
3.6
2.9
—
—
—
0
0
43
390
1.16
0.29
3.3
3.3
6.63
6.15
ph
1.80
23
213
5
71
0.69
0.27
1.0
1.2
—
—
—
0
0
5
73
0.67
0.27
28.6
11.5
0.38
0.64
%
—
5
73
24
210
1.18
0.24
4.1
3.6
1.02
1.02
kg/l
0.03
17
129
50
464
1.14
0.24
1.9
2.0
92.39
94.56
pmol/l
0.12
19
231
7
90
0.76
0.23
1.3
1.6
—
—
—
0
0
5
41
1.23
0.22
1.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
91.56
—
0
10
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
1.70
—
0
12
0
12
0.00
0.21
0.0
1.4
—
34.25
—
0
12
29
261
1.15
0.21
4.4
2.8
0.21
0.28
e6/l
0.25
22
190
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
6
50
1.21
0.20
2.5
2.3
—
—
—
0
0
6
51
1.19
0.20
4.5
3.6
1.02
1.02
ratio
—
6
46
6
52
1.16
0.19
1.5
2.2
0.58
0.59
%
—
6
52
23
256
0.87
0.18
2.8
2.7
0.61
0.74
ug/l
0.74
18
158
10
82
1.24
0.17
15.6
12.0
—
—
—
0
0
5
67
0.73
0.17
14.6
3.3
—
—
—
0
0
11
94
1.19
0.13
1.1
1.3
—
—
—
0
0
48
503
0.92
0.12
4.5
3.6
0.00
0.00
estimate
—
6
91
32
299
1.10
0.12
1.8
1.6
20.51
19.59
nmol/l
0.12
27
248
100
983
1.13
0.11
35.0
18.5
80.08
81.96
umol/l
0.31
100
971
25
232
1.10
0.11
2.2
1.7
0.86
1.21
mg/l
0.69
17
188
24
258
0.91
0.10
5.3
3.5
0.00
0.00
estimate
—
6
89
6
54
1.12
0.09
1.5
2.1
1.85
1.08
%
—
6
54
19
205
0.91
0.08
1.2
1.3
0.72
1.79
u/ml
—
5
63
96
946
1.09
0.07
21.4
12.6
—
—
—
0
0
41
421
0.96
0.04
4.2
3.7
32.22
47.60
ng/l
0.49
35
301
48
487
0.98
0.01
4.5
3.6
0.00
0.00
estimate
—
7
93
49
497
0.98
0.01
4.5
3.6
0.00
0.00
estimate
—
7
99
14
142
0.98
0.00
11.9
7.6
102.36
104.99
mmol/l
0.94
14
142
18
179
1.01
0.00
1.6
1.7
1077.15
1303.47
nmol/l
0.51
12
145
100
1001
0.99
0.00
39.6
21.0
6.31
6.62
e9/l
1.01
100
977
100
1001
0.99
0.00
39.5
20.9
30.12
30.53
pg
1.65
100
988
100
1001
0.99
0.00
39.7
21.1
129.05
137.67
g/l
6.19
100
987
100
1001
0.99
0.00
40.9
21.6
38.77
41.02
%
5.38
100
988
100
1001
0.99
0.00
39.6
21.0
4.32
4.54
e12/l
3.52
100
976
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
284.70
—
0
5
0
5
0.00
0.00
0.0
1.8
—
0.60
—
0
5
0
9
0.00
0.00
0.0
1.2
—
99.44
—
0
9
0
5
0.00
0.00
0.0
8.8
—
1337.00
—
0
5
0
5
0.00
0.00
0.0
1.2
—
201.93
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
164.55
—
0
8
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
65
0.92
-0.00
2.3
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
28.75
—
0
6
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
15.3
—
0.63
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
100
1000
1.00
-0.00
39.5
21.0
90.25
91.52
fl
2.28
100
987
0
6
0.00
-0.00
0.0
2.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
283.00
—
0
6
7
72
0.97
-0.00
1.6
1.3
—
—
—
0
0
6
64
0.93
-0.00
1.5
1.4
—
27.29
—
0
7
6
69
0.86
-0.00
1.3
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
100
1000
1.00
-0.00
39.6
21.0
244.02
241.32
e9/l
0.15
100
981

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_NASOPHARYNX – Malignant neoplasm of nasopharynx

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).